Signal Evaluation & Management Webinar by Cliniminds India

Cliniminds organised Webinar on Fundamentals #SignalEvaluation & Management by Dr. Anupama Dambalkar with over 7 years of experience as Senior #DrugSafety Physician, with extensive experience in #SignalManagement. #pharmacovigilance
Topics covered:
1. Introduction to signal Management
2. Sources of Signals
3. Signal Management Processes
4. Recommendation for Action
5. Communication
6. Summary and Quality Check
For more information, admissions please contact us 9910068241, 9560102589, 9910068241 or write us at [e-mail]
#clinicalresearchcourses, #pharmacovigilancecourses, #pharmacovigilancecoursesinIndia
(1)Aggregate Report Writing video link:
• Aggregate Report Writi...
(2)MACHINE LEARNING & CAREER AS DATA SCIENTIST
• DEMO SESSION ON MACHIN...
(3)ICH-GCP Session -Faculty Development Program at Amity Institute of Pharmacy
• ICH-GCP Session -Facul...
(4)Pharmacovigilance as a Career for Pharmacy Graduates & Post Graduates (Part I)
• Pharmacovigilance as a...
Follow us on:
Instagram: clinimindsi...
Linkedin: / cliniminds-pharmacovig...
Facebook: / clinimindsnoida

[@avsghasiya]

What's the first ref link at the bottom of slide at 21:38 mark? It's covered by the gotomeeting notification.

[@suchanderreddy]

11:04

[@user-fj4bp4te1x]

sir is there any problem related to the signal detection and how can we handle it?

[@ClinimindsIndia]

Call /Whatsapp [phone]

[@PADAMATIRAJLANKA]

When is the new batch is getting started

[@ClinimindsIndia]

Signal new batch starting from 07th May 2022 ( Weekend online e learning ) and Aggregate New batch starting from 30th May 2022 ( weekend e learning ) for more information contact Mr .Rajat Sharma 9910068241

[@LG-ml5lu]

11:35-Off-label use is not about any change in dose or mode of administration. Rather, it's related to the usage of drug outside of approved/authorized indications. Any safety concern arising due to off-label usage is again considered as a safety signal.
🇬🇧 🙏